funding
Basecamp Research Series C: $140M for EDEN Therapeutics
Basecamp Research announced a $140 million Series C led by S32 on Sept. 23, 2026 to train new EDEN models for therapeutics. No valuation on the primary wire.
Ultrathink's source-backed coverage of Foundation Models. 2 stories so far. Latest, on : Basecamp Research Series C: $140M for EDEN Therapeutics.